Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans

J Infect Dis. 2001 Sep 15;184(6):665-70. doi: 10.1086/323085. Epub 2001 Aug 9.

Abstract

This study developed methods and determined the impact of influenza vaccination on elderly persons in 3 large health plans: Kaiser Permanente Northwest, HealthPartners, and Oxford Health Plans. Data for the 1996-1997 and 1997-1998 seasons were extracted from administrative databases. Subjects were health plan members > or = 65 years old. Comorbid conditions collected from the preceding year were used for risk adjustment with logistic regression. The virus-vaccine match was excellent for year 1 and fair for year 2. Both years, during peak and total periods, vaccination reduced all causes of death and hospitalization for pneumonia and influenza: hospitalizations were reduced by 19%-20% and 18%-24% for years 1 and 2, respectively, and deaths were reduced by 60%-61% and 35%-39% for the same periods. These results show that all elderly persons should be immunized annually for influenza. The methods used in this study are an efficient cost-effective way to study vaccine impact and similar questions.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Age Factors
  • Aged
  • Health Maintenance Organizations / statistics & numerical data*
  • Hospitalization / statistics & numerical data*
  • Humans
  • Influenza Vaccines*
  • Influenza, Human / epidemiology*
  • Influenza, Human / mortality
  • Influenza, Human / prevention & control*
  • Inpatients / statistics & numerical data
  • Minnesota
  • New York
  • Oregon
  • Outpatients / statistics & numerical data
  • Regression Analysis
  • Risk Assessment
  • Risk Factors
  • Seasons
  • Time Factors

Substances

  • Influenza Vaccines